Comparison of Articaine and Lidocaine as an anesthetic supplemental injectio

Phase 3

• Conditions: Irreversible pulpitis.; Streptococcus and staphylococcus as the cause of diseases classified to other chapters

• Registration Number: IRCT2015100523253N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Patients older than 18 without any systemic diseases; First or second mandibular molar with irreversible pulpitis; No periapical lesion in radiography; Response to Electrical Pulp Tester; Prolonged response to the cold test

Exclusion Criteria

Allergic response to Lidocaine or Articaine; pre apical radiolucency; Lactate or pregnant women; Using analgesic drugs since 12 hours before the treatment; Mobility more than 0.5 mm; Probing more than 3 mm in mesial and distal; Severe dental pain that needs emergency treatment; Nonvital coronal pulp tissue; Teeth with full crown; No lip numbness after the Inferior Alveolar Nerve Block injection; No pulp exposure after removing caries

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anesthesia. Timepoint: After Inferior Alveolar Nerve Block injection; After supplemental injection. Method of measurement: Electrical pulp tester.;Pulse. Timepoint: Before Inferior Alveolar Nerve Block injection; After Inferior Alveolar Nerve Block injection; After supplemtal injection. Method of measurement: Pulse-oximeter.;Pain during injection. Timepoint: During Inferior Alveolar Nerve Block and supplemental injection. Method of measurement: Heft Parker Visual Analog Scale.;Pain. Timepoint: After Inferior Alveolar Nerve Block and supplemental injection. Method of measurement: Heft Parker Visual Analog Scale.